Viz ANEURYSM vs Viz SDH
AI Verdict
Choose Viz ANEURYSM if…
Choose Viz ANEURYSM if your primary need is the rapid, AI-powered detection of suspected cerebral aneurysms from CT angiograms (CTAs) to streamline neurovascular care. This tool is ideal for institutions focused on optimizing the workflow for aneurysm assessment, leveraging AI-enhanced 3D imaging and facilitating timely patient management through coordinated care teams.
View Viz ANEURYSM →Choose Viz SDH if…
Choose Viz SDH if your priority is the automatic detection and quantification of acute and chronic subdural hemorrhage on non-contrast CT images for effective triage and optimal neurosurgical care. This solution is particularly well-suited for scenarios requiring real-time alerts to specialists and detailed measurements of subdural collections, including volume and midline shift, to guide urgent interventions.
View Viz SDH →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz ANEURYSM | Viz SDH |
|---|---|---|
| Pricing | Contact for pricing | Subscription |
| Deployment | Cloud-based; Standalone application; Mobile software module | Cloud-based; available on mobile, web, and within the radiology workflow. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz ANEURYSMBoth tools offer streamlined workflows, real-time notifications, and mobile access, indicating a strong focus on usability. However, Viz ANEURYSM specifically highlights 'AI-enhanced 3D imaging (Viz 3D CTA)' and 'interactive tools for neurovascular assessment,' suggesting a potentially richer and more specialized user experience for complex 3D visualization and interaction critical for aneurysm evaluation.
Clinical Value
Viz SDHBoth tools provide significant clinical value by enabling early detection and care coordination for critical neurovascular conditions. Viz SDH, however, offers an additional 'Quantification of subdural collections, including volume, thickness, and midline shift' feature with its Viz SDH+ module. This provides objective, actionable metrics beyond simple detection, which can be highly valuable for clinical decision-making and patient management.
Pricing & Value
Viz SDHWhile both are subscription-based for enterprise clients, Viz SDH provides more transparency regarding its pricing structure, stating an 'Annual fee based on the number of algorithms used and the size of the population served.' This offers a clearer understanding of how costs are determined and scaled, compared to Viz ANEURYSM's 'Contact for pricing' which provides less initial detail.
Enterprise Readiness
TieBoth Viz ANEURYSM and Viz SDH demonstrate strong enterprise readiness. They are FDA-cleared, HIPAA compliant, include Business Associate Agreements (BAA), and are deployed as cloud-based solutions with mobile and web access. As products from the same established vendor, Viz.ai, they share a common foundation of robust infrastructure and compliance necessary for healthcare enterprises.
Innovation
Viz ANEURYSMBoth tools leverage AI for critical disease detection and care coordination. Viz ANEURYSM stands out with its explicit mention of 'AI-enhanced 3D imaging (Viz 3D CTA),' which represents a significant innovation in visualizing and analyzing complex vascular structures for aneurysm assessment. While Viz SDH's quantification is valuable, the advanced 3D imaging for aneurysms pushes the boundaries of AI in diagnostic imaging for a highly specialized condition.
Support & Docs
TieBoth tools are products of Viz.ai, a company that offers comprehensive customer support, including 24/7 urgent phone support, email support, in-app assistance, a knowledge base, and customer resources like user guides and Viz Academy. Given they originate from the same vendor and are enterprise-grade solutions, it is reasonable to conclude they benefit from the same robust level of support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz ANEURYSM | Viz SDH |
|---|---|---|
| Product Name | Viz ANEURYSM | Viz SDH |
| Description | Viz ANEURYSM is an FDA-cleared AI-powered solution by Viz.ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management. | AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care. |
| Company | Viz.ai | Viz.ai |
| Tagline | AI-Powered Neurovascular Care Coordination | AI-powered disease detection and intelligent care coordination |
| Primary Detection Focus | Suspected cerebral aneurysms in CT angiograms (CTAs) | Acute and chronic subdural hemorrhage on non-contrast CT images |
| Key Feature 1 | Auto-detection of suspected cerebral aneurysms in CTAs | Automatic AI detection of acute and chronic subdural hemorrhage on non-contrast CT images. |
| Key Feature 2 | AI-enhanced 3D imaging (Viz 3D CTA) | Real-time notification to neurovascular or neurosurgical specialists. |
Videos
Demos, reviews, and walkthroughs featuring Viz ANEURYSM and Viz SDH.
Frequently Asked Questions
More Comparisons
More matchups featuring Viz ANEURYSM or Viz SDH
Backers
Who funded each tool's parent company.